1 drug(s) with this reaction
355 total reports
Injection Site Mass has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 355 adverse event reports mention injection site mass in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with injection site mass, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have injection site mass listed in their FDA adverse event reports, sorted by report count:
In addition to injection site mass, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have injection site mass listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 355 reports of injection site mass across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.